Robert Glanzman, MD

Articles

Robert Glanzman, MD: Overview of CNM-Au8

March 17, 2020

The chief medical officer of Clene Nanomedicine detailed CNM-Au8, their novel investigational drug currently being assessed in multiple trials for patients with multiple sclerosis and other neurodegenerative diseases.